GOP Sidestepped Medicare Drug Price Negotiation At Becerra Hearings

By John Wilkerson / March 1, 2021 at 3:00 PM
FDA authorized Johnson & Johnson’s coronavirus vaccine over the weekend, and pharma is hoping coronavirus vaccines inoculate industry against drug pricing legislation, but there are still worrying signs for drug makers, including the absence of Republican questions about Medicare price negotiation during two confirmation hearings last week for HHS Secretary-nominee Xavier Becerra. With emergency use authorization granted to the third coronavirus vaccine, there is expected to be ample vaccine supply for Americans this year, and brand drug makers are hoping...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.